Results 1 to 10 of about 818,267 (303)
Pulmonology, 2020 Introduction Chronic hypersensitivity pneumonitis (CHP) is an interstitial lung disease with limited treatment response and bad prognosis. Sometimes it is indistinguishable from idiopathic pulmonary fibrosis (IPF) becoming one of the main differential ...
Maria Laura Alberti +6 more
doaj +3 more sources
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis
Respiratory Research, 2022 Background Advanced pulmonary sarcoidosis causes significant morbidity and can lead to death. Large trials demonstrated efficacy of antifibrotics in patients with progressive fibrosing interstitial lung diseases (PF-ILD), including a few with sarcoidosis.
M. C. Schimmelpennink +7 more
doaj +1 more source
Interstitial implant with interstitial hyperthermia [PDF]
Cancer, 1982 A Phase I Pilot Study combining interstitial or intracavitary irradiation using 192Ir or 137Cs and interstitial hyperthermia in advanced or recurrent tumors is underway at the City of Hope National Medical Center. Hyperthermia is performed using 0.5 megahertz RF (500 kilohertz) radiofrequency localized current fields.
N, Vora +4 more
openaire +2 more sources
Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis [PDF]
Investigative and Clinical Urology, 2020 After decades of clinical and basic science research, the clinical application of botulinum toxin A (Botox) in urology has been extended to neurogenic detrusor overactivity (NDO), idiopathic detrusor overactivity, refractory overactive bladder (OAB ...
Jing-Liang Chen , Hann-Chorng Kuo
doaj +1 more source
Advances in urinary biomarker discovery in urological research [PDF]
Investigative and Clinical Urology, 2020 A disease-specific biomarker (or biomarkers) is a characteristic reflecting a pathological condition in human body, which can be used as a diagnostic or prognostic tool for the clinical management.
Jayoung Kim , Won Tae Kim , Wun-Jae Kim
doaj +1 more source
Clustering of lung diseases in the family of interstitial lung disease patients
BMC Pulmonary Medicine, 2022 Background The presence of familial interstitial lung disease (ILD) has been found to predict development of progressive pulmonary fibrosis. However, the role of non-ILD lung diseases in ILD patients’ families has not yet been investigated.
Michelle Terwiel +2 more
doaj +1 more source
Frontiers in Oncology, 2022 PurposeThe aim of this study is to evaluate the efficacy and toxicity of image-guided high-dose rate (HDR) interstitial brachytherapy (ISBT) for the reirradiation of cervical cancer within a previously irradiated area.Methods and materialsTwenty-three ...
Xiaojun Ren +8 more
doaj +1 more source
Drug-Induced interstitial pneumonitis in a case of breast malignancy
Journal of Association of Pulmonologist of Tamil Nadu, 2022 Drugs used in the treatment of diseases including malignancy are known to cause various lung injuries, including interstitial pneumonitis. With increasing incidence of malignancies and advent of newer and newer chemotherapy and immunological treatments ...
Hemalatha Padmanathan +5 more
doaj +1 more source
Molecules, 2023 In the course of action potential firing, all axons and neurons release K+ from the intra- cellular compartment into the interstitial space to counteract the depolarizing effect of Na+ influx, which restores the resting membrane potential. This efflux of
Hana Beswick-Jones +2 more
doaj +1 more source
Comorbidities in interstitial lung diseases
European Respiratory Review, 2017 Fibrosing lung disorders include a large number of diseases with diverse behaviour. Patients can die because of the progression of their illness, remain stable or even improve after appropriate treatment has been instituted.
George A. Margaritopoulos +2 more
doaj +1 more source